1-9 of 9
William J Harrington, Jr.
Close
Sort by
Journal Articles

Adult T Cell Leukemia/Lymphoma Development in HTLV-1-Infected Humanized SCID Mice.

Prabal Banerjee, PhD, Michael D Lairmore, DVM, PhD, Juan Carlos Ramos, MD, William J Harrington, Jr., Mark A Beilke, Gerold Feuer, PhD
Journal: Blood
Blood (2009) 114 (22): 1425.
https://doi.org/10.1182/blood.V114.22.1425.1425
Published: 2009
Journal Articles

First Line Antiviral Therapy Significantly Improves Survival of Patients with Acute, Chronic and Smoldering ATL: a Worldwide Meta-Analysis.

Ali Bazarbachi, MD, PhD, Yves Plumelle, Juan Carlos Ramos, MD, Patricia Tortevoye, Zaher Otrock, Graham Taylor, Antoine Gessain, William J Harrington, Jr., Gérard Panelatti, Olivier Hermine
Journal: Blood
Blood (2009) 114 (22): 108.
https://doi.org/10.1182/blood.V114.22.108.108
Published: 2009
Journal Articles

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma

Brief Report
Andrea J. O'Hara, Ling Wang, Bruce J. Dezube, William J. Harrington, Jr, Blossom Damania, Dirk P. Dittmer
Journal: Blood
Blood (2009) 113 (23): 5938–5941.
https://doi.org/10.1182/blood-2008-09-179168
Published: 2009
Includes: Supplemental data
Journal Articles

HTLV-1 Infection of Human Hematopoietic Stem Cells Induces a Novel T Cell Lymphoma in Humanized SCID Mice

Prabal Banerjee, PhD, Lindsey Crawford, Michelle Sieburg, Patrick Green, PhD, Mark A Beilke, MD, William J Harrington, Jr., MD, Michael D Lairmore, DVM, PhD, Gerold Feuer, PhD
Journal: Blood
Blood (2008) 112 (11): 1359.
https://doi.org/10.1182/blood.V112.11.1359.1359
Published: 2008
Journal Articles

IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma

Juan Carlos Ramos, Phillip Ruiz, Jr, Lee Ratner, Isildinha M. Reis, Carlos Brites, Celia Pedroso, Gerald E. Byrne, Jr, Ngoc L. Toomey, Valentine Andela, Edward W. Harhaj, Izidore S. Lossos, William J. Harrington, Jr
Journal: Blood
Blood (2006) 109 (7): 3060–3068.
https://doi.org/10.1182/blood-2006-07-036368
Published: 2006
Journal Articles

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

Sang-Hoon Sin, Debasmita Roy, Ling Wang, Michelle R. Staudt, Farnaz D. Fakhari, Dhavalkumar D. Patel, David Henry, William J. Harrington, Jr, Blossom A. Damania, Dirk P. Dittmer
Journal: Blood
Blood (2006) 109 (5): 2165–2173.
https://doi.org/10.1182/blood-2006-06-028092
Published: 2006
Includes: Supplemental data
Journal Articles

Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells

Esther A. Obeng, Louise M. Carlson, Delia M. Gutman, William J. Harrington, Jr, Kelvin P. Lee, Lawrence H. Boise
Journal: Blood
Blood (2006) 107 (12): 4907–4916.
https://doi.org/10.1182/blood-2005-08-3531
Published: 2006
Journal Articles

Azidothymidine inhibits NF-κB and induces Epstein-Barr virus gene expression in Burkitt lymphoma

Motoki Kurokawa, Subrata K. Ghosh, Juan Carlos Ramos, Abdul M. Mian, Ngoc L. Toomey, Lisa Cabral, Denise Whitby, Glen N. Barber, Dirk P. Dittmer, William J. Harrington, Jr
Journal: Blood
Blood (2005) 106 (1): 235–240.
https://doi.org/10.1182/blood-2004-09-3748
Published: 2005
Journal Articles

Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κB

Clinical Trials & Observations
Subrata K. Ghosh, Charles Wood, Lawrence H. Boise, Abdul M. Mian, Vadim V. Deyev, Gerold Feuer, Ngoc L. Toomey, Nicole C. Shank, Lisa Cabral, Glen N. Barber, William J. Harrington, Jr
Journal: Blood
Blood (2003) 101 (6): 2321–2327.
https://doi.org/10.1182/blood-2002-08-2525
Published: 2003